Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Elejalde I"'
Autor:
Teijeira L; Servicio de Oncología Médica, Hospital Universitario de Navarra, 31008 Pamplona, Spain., Martínez M; Servicio de Oncología Médica, Hospital Universitario Araba, Servicio Vasco de Salud Osakidetza, 01009 Vitoria-Gasteiz, Spain.; Grupo de Investigación en Cáncer de Pulmón, Instituto de Investigación Sanitaria Bioaraba, 01009 Vitoria-Gasteiz, Spain., Moreno A; Servicio de Oncología Médica, Hospital Universitario Galdakao, 48960 Galdácano, Spain., de Elejoste I; Servicio de Oncología Médica, Hospital Universitario Donostia, 20014 San Sebastián, Spain., Ibáñez-Beroiz B; Servicio de Metodología, IdISNA, Navarrabiomed-Universidad Pública de Navarra, 31008 Pamplona, Spain., Arrazubi V; Servicio de Oncología Médica, Hospital Universitario de Navarra, 31008 Pamplona, Spain., Díaz de Corcuera I; Servicio de Oncología Médica, Hospital Universitario Galdakao, 48960 Galdácano, Spain., Elejalde I; Servicio de Medicina Interna, Hospital Universitario de Navarra, 31008 Pamplona, Spain.; Unidad de Enfermedades Autoinmunes Sistémicas, Servicio de Medicina Interna, Hospital Universitario de Navarra, 31008 Pamplona, Spain.; Grupo de Enfermedades Inflamatorias e Inmunomediadas, IdISNA, Navarrabiomed-Universidad Pública de Navarra, 31008 Pamplona, Spain., Campillo-Calatayud A; Grupo de Enfermedades Inflamatorias e Inmunomediadas, IdISNA, Navarrabiomed-Universidad Pública de Navarra, 31008 Pamplona, Spain., Les I; Servicio de Medicina Interna, Hospital Universitario de Navarra, 31008 Pamplona, Spain.; Unidad de Enfermedades Autoinmunes Sistémicas, Servicio de Medicina Interna, Hospital Universitario de Navarra, 31008 Pamplona, Spain.; Grupo de Enfermedades Inflamatorias e Inmunomediadas, IdISNA, Navarrabiomed-Universidad Pública de Navarra, 31008 Pamplona, Spain.; Departamento de Ciencias de la Salud, Universidad Pública de Navarra, 31008 Pamplona, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Dec 28; Vol. 16 (1). Date of Electronic Publication: 2023 Dec 28.
Autor:
Heras, H., Ruiz-Arruza, I., Diestefano, L., Solanich, X., García, O., Artaraz, J., de Ramón-Garrido, E., Jódar-Márquez, M., Rodriguez-Carballeira, M., Mousavi, K., López-Dupla, M., Porras-Ledantes, J.A., Sole-Forteza, E., Rosello-Silvestre, N., Añón-Roig, M.S., Fernandez-Matilla, M., Chaques, V., Arroyo, C., Madroñero-Vuelta, A.B., Jimenez-Lasanta, L., Martín-Armada, M., Bueno, C., Elejalde, I., Echeverria, M., Compains, E., Solanich-Moreno, X., Garcia-Garcia, O., Garcia-Bru, P., Carrillo-Alascio, P.L., Ruiz-Nicolás, C., Llorenç, V., Mesquida, M., Eguiluz, S., Anaut, P., Larrauri, A., Gómez, A., Callejas-Rubio, J.L., Ríos-Fernández, R., Ortego-Centeno, N., García-Serrano, J.L., Castro, A., Parra, S., Baiget, M., Chara-Cervantes, J., Ayats-Vidal, S., Navarrete, N., Espejo, A., Herranz, M.T., Losada, M., Martinez-Valle, F., Blanco-Daroca, M., Aizpurua-Manso, I., Perales-Fraile, I., García-Gil de Bernabé, J., Santander-García, D., Esteban-Marcos, E., Pallares-Ferreres, L., Olea-Vallejo, J.L., Mateo-Poch, J.M., Aragón-Roca, J.A., Fanlo, P., Espinosa, G., Adan, A., Fonollosa, A., Segura, A.
Publikováno v:
In Revista Clínica Española (English Edition) April 2021 221(4):221-225
Autor:
Heras, H., Ruiz-Arruza, I., Diestefano, L., Solanich, X., García, O., Artaraz, J., de Ramón-Garrido, E., Jódar-Márquez, M., Rodriguez-Carballeira, M., Mousavi, K., López-Dupla, M., Porras-Ledantes, J.A., Sole-Forteza, E., Rosello-Silvestre, N., Añón-Roig, M.S., Fernandez-Matilla, M., Chaques, V., Arroyo, C., Madroñero-Vuelta, A.B., Jimenez-Lasanta, L., Martín-Armada, M., Bueno, C., Elejalde, I., Echeverria, M., Compains, E., Solanich-Moreno, X., Garcia-Garcia, O., Garcia-Bru, P., Carrillo-Alascio, P.L., Ruiz-Nicolás, C., Llorenç, V., Mesquida, M., Eguiluz, S., Anaut, P., Larrauri, A., Gómez, A., Callejas-Rubio, J.L., Ríos-Fernández, R., Ortego-Centeno, N., García-Serrano, J.L., Castro, A., Parra, S., Baiget, M., Chara-Cervantes, J., Ayats-Vidal, S., Navarrete, N., Espejo, A., Herranz, M.T., Losada, M., Martinez-Valle, F., Blanco-Daroca, M., Aizpurua-Manso, I., Perales-Fraile, I., García-Gil de Bernabé, J., Santander-García, D., Esteban-Marcos, E., Pallares-Ferreres, L., Olea-Vallejo, J.L., Mateo-Poch, J.M., Aragón-Roca, J.A., Fanlo, P., Espinosa, G., Adan, A., Fonollosa, A., Segura, A.
Publikováno v:
In Revista clinica espanola April 2021 221(4):221-225
Autor:
Les I; Internal Medicine Department, Navarre University Hospital, 31008 Pamplona, Spain.; Autoimmune Diseases Unit, Internal Medicine Department, Navarre University Hospital, 31008 Pamplona, Spain.; Inflammatory and Immune-Mediated Diseases Group, Instituto de Investigación Sanitaria de Navarra (IdISNA), Navarrabiomed-Public University of Navarre, 31008 Pamplona, Spain., Martínez M; Osakidetza Basque Health Service, Department of Medical Oncology, Araba University Hospital, 01009 Vitoria-Gasteiz, Spain.; Lung Cancer Research Group, Bioaraba Health Research Institute, 01006 Vitoria-Gasteiz, Spain., Pérez-Francisco I; Breast Cancer Research Group, Bioaraba Health Research Institute, 01006 Vitoria-Gasteiz, Spain., Cabero M; Clinical Trials Platform, Bioaraba Health Research Institute, 01006 Vitoria-Gasteiz, Spain., Teijeira L; Medical Oncology Department, Navarre University Hospital, 31008 Pamplona, Spain., Arrazubi V; Medical Oncology Department, Navarre University Hospital, 31008 Pamplona, Spain., Torrego N; Osakidetza Basque Health Service, Department of Medical Oncology, Araba University Hospital, 01009 Vitoria-Gasteiz, Spain.; Lung Cancer Research Group, Bioaraba Health Research Institute, 01006 Vitoria-Gasteiz, Spain., Campillo-Calatayud A; Inflammatory and Immune-Mediated Diseases Group, Instituto de Investigación Sanitaria de Navarra (IdISNA), Navarrabiomed-Public University of Navarre, 31008 Pamplona, Spain., Elejalde I; Internal Medicine Department, Navarre University Hospital, 31008 Pamplona, Spain.; Autoimmune Diseases Unit, Internal Medicine Department, Navarre University Hospital, 31008 Pamplona, Spain.; Inflammatory and Immune-Mediated Diseases Group, Instituto de Investigación Sanitaria de Navarra (IdISNA), Navarrabiomed-Public University of Navarre, 31008 Pamplona, Spain., Kochan G; Oncoimmunology Group, Instituto de Investigación Sanitaria de Navarra (IdISNA), Navarrabiomed-Public University of Navarre, 31008 Pamplona, Spain., Escors D; Oncoimmunology Group, Instituto de Investigación Sanitaria de Navarra (IdISNA), Navarrabiomed-Public University of Navarre, 31008 Pamplona, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Mar 06; Vol. 15 (5). Date of Electronic Publication: 2023 Mar 06.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Les I; Internal Medicine Department, Navarra University Hospital, Pamplona, Spain.; Autoimmune Diseases Unit, Internal Medicine Department, Navarra University Hospital, Pamplona, Spain., Pérez-Francisco I; Bioaraba Health Research Institute, Breast Cancer Research Group, Vitoria-Gasteiz, Spain., Cabero M; Bioaraba Health Research Institute, Clinical Trials Platform, Vitoria-Gasteiz, Spain., Sánchez C; Osakidetza Basque Health Service, Araba University Hospital, Department of Internal Medicine, Vitoria-Gasteiz, Spain., Hidalgo M; Osakidetza Basque Health Service, Araba University Hospital, Department of Medical Oncology, Vitoria-Gasteiz, Spain., Teijeira L; Medical Oncology Department, Navarra University Hospital, Pamplona, Spain., Arrazubi V; Medical Oncology Department, Navarra University Hospital, Pamplona, Spain., Domínguez S; Bioaraba Health Research Institute, Breast Cancer Research Group, Vitoria-Gasteiz, Spain.; Osakidetza Basque Health Service, Araba University Hospital, Department of Medical Oncology, Vitoria-Gasteiz, Spain., Anaut P; Osakidetza Basque Health Service, Araba University Hospital, Department of Internal Medicine, Vitoria-Gasteiz, Spain., Eguiluz S; Osakidetza Basque Health Service, Araba University Hospital, Department of Internal Medicine, Vitoria-Gasteiz, Spain., Elejalde I; Internal Medicine Department, Navarra University Hospital, Pamplona, Spain.; Autoimmune Diseases Unit, Internal Medicine Department, Navarra University Hospital, Pamplona, Spain., Herrera A; Osakidetza Basque Health Service, Araba University Hospital, Department of Immunology, Vitoria-Gasteiz, Spain., Martínez M; Osakidetza Basque Health Service, Araba University Hospital, Department of Medical Oncology, Vitoria-Gasteiz, Spain.; Bioaraba Health Research Institute, Lung Cancer Research Group, Vitoria-Gasteiz, Spain.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2022 Jun 01; Vol. 13, pp. 894550. Date of Electronic Publication: 2022 Jun 01 (Print Publication: 2022).
Autor:
Les I; Internal Medicine Department, Navarra Hospital Complex, Pamplona, Spain.; Autoimmune Diseases Unit, Internal Medicine Department, Navarra Hospital Complex, Pamplona, Spain., Loureiro-Amigo J; Internal Medicine Department, Moisès Broggi Hospital, Consorci Sanitari Integral, Sant Joan Despí, Barcelona, Spain., Capdevila F; Hospital Pharmacy Department, Navarra Hospital Complex, Public University of Navarra, Healthcare Research Institute of Navarra, Pamplona, Spain., Oriol I; Internal Medicine Department, Moisès Broggi Hospital, Consorci Sanitari Integral, Sant Joan Despí, Barcelona, Spain.; Infectious Diseases Unit, Internal Medicine Department, Moisès Broggi Hospital, Consorci Sanitari Integral, Sant Joan Despí, Barcelona, Spain., Elejalde I; Internal Medicine Department, Navarra Hospital Complex, Pamplona, Spain.; Autoimmune Diseases Unit, Internal Medicine Department, Navarra Hospital Complex, Pamplona, Spain., Aranda-Lobo J; Internal Medicine Department, Moisès Broggi Hospital, Consorci Sanitari Integral, Sant Joan Despí, Barcelona, Spain., Modesto J; Internal Medicine Department, Navarra Hospital Complex, Pamplona, Spain., Güell-Farré E; Internal Medicine Department, Moisès Broggi Hospital, Consorci Sanitari Integral, Sant Joan Despí, Barcelona, Spain., García R; Clinical Trials Platform, Navarrabiomed, Navarra Hospital Complex, Public University of Navarra, Healthcare Research Institute of Navarra, Pamplona, Spain., Murgadella-Sancho A; Hospital Pharmacy Department, Moisès Broggi Hospital, Consorci Sanitari Integral, Sant Joan Despí, Barcelona, Spain., Anniccherico J; Internal Medicine Department, Navarra Hospital Complex, Pamplona, Spain., Martín-Fernández M; Internal Medicine Department, Moisès Broggi Hospital, Consorci Sanitari Integral, Sant Joan Despí, Barcelona, Spain., Lorza JJ; Pneumology Department, Navarra Hospital Complex, Pamplona, Spain., Monteys-Montblanch JP; Internal Medicine Department, Moisès Broggi Hospital, Consorci Sanitari Integral, Sant Joan Despí, Barcelona, Spain., Librero J; Navarrabiomed, Navarra Hospital Complex, Public University of Navarra, Healthcare Research Institute of Navarra, Pamplona, Spain., Pintado-Lalueza S; Internal Medicine Department, Moisès Broggi Hospital, Consorci Sanitari Integral, Sant Joan Despí, Barcelona, Spain., Delgado M; Medical Oncology Department, Navarra Hospital Complex, Pamplona, Spain., Gracia-García B; Hospital Pharmacy Department, Moisès Broggi Hospital, Consorci Sanitari Integral, Sant Joan Despí, Barcelona, Spain., Sánchez-Álvarez J; Internal Medicine Department, Navarra Hospital Complex, Pamplona, Spain., Pestaña-Fernández M; Internal Medicine Department, Moisès Broggi Hospital, Consorci Sanitari Integral, Sant Joan Despí, Barcelona, Spain., Fanlo P; Internal Medicine Department, Navarra Hospital Complex, Pamplona, Spain.; Autoimmune Diseases Unit, Internal Medicine Department, Navarra Hospital Complex, Pamplona, Spain., Funalleras-Puig G; Internal Medicine Department, Moisès Broggi Hospital, Consorci Sanitari Integral, Sant Joan Despí, Barcelona, Spain., Sarobe M; Hospital Pharmacy Department, Navarra Hospital Complex, Public University of Navarra, Healthcare Research Institute of Navarra, Pamplona, Spain., Mediavilla E; Emergency Department, Navarra Hospital Complex, Pamplona, Spain., Ibero C; Internal Medicine Department, Navarra Hospital Complex, Pamplona, Spain.; Infectious Diseases Unit, Navarra Hospital Complex, Pamplona, Spain.
Publikováno v:
Frontiers in medicine [Front Med (Lausanne)] 2022 Feb 28; Vol. 9, pp. 807981. Date of Electronic Publication: 2022 Feb 28 (Print Publication: 2022).
Publikováno v:
Anales del Sistema Sanitario de Navarra, Volume: 40, Issue: 2, Pages: 291-294, Published: AUG 2017
Resumen El olmesartán es un antagonista del receptor tipo 1 de la angiotensina II utilizado habitualmente en el tratamiento de pacientes con hipertensión arterial. Recientemente se han descrito varios casos de enteropatía sprue-like asociados al u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______624::ef54c5ee43e8e2cf5d02abf1b6142734
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1137-66272017000200291&lng=en&tlng=en
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1137-66272017000200291&lng=en&tlng=en
Publikováno v:
Anales del Sistema Sanitario de Navarra v.40 n.2 2017
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Resumen El olmesartán es un antagonista del receptor tipo 1 de la angiotensina II utilizado habitualmente en el tratamiento de pacientes con hipertensión arterial. Recientemente se han descrito varios casos de enteropatía sprue-like asociados al u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::ef54c5ee43e8e2cf5d02abf1b6142734
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1137-66272017000200291
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1137-66272017000200291
Autor:
Fanlo, P., Espinosa, G., Adan, A., Fonollosa, A., Segura, A., Heras, H., Ruiz-Arruza, I., Diestefano, L., Solanich, X., García, O., Artaraz, J., de Ramón-Garrido, E., Jódar-Márquez, M., Rodriguez-Carballeira, M., Mousavi, K., López-Dupla, M., Porras-Ledantes, J.A., Sole-Forteza, E., Rosello-Silvestre, N., Añón-Roig, M.S., Fernandez-Matilla, M., Chaques, V., Arroyo, C., Madroñero-Vuelta, A.B., Jimenez-Lasanta, L., Martín-Armada, M., Bueno, C., Elejalde, I., Echeverria, M., Compains, E., Solanich-Moreno, X., Garcia-Garcia, O., Garcia-Bru, P., Carrillo-Alascio, P.L., Ruiz-Nicolás, C., Llorenç, V., Mesquida, M., Eguiluz, S., Anaut, P., Larrauri, A., Gómez, A., Callejas-Rubio, J.L., Ríos-Fernández, R., Ortego-Centeno, N., García-Serrano, J.L., Castro, A., Parra, S., Baiget, M., Chara-Cervantes, J., Ayats-Vidal, S., Navarrete, N., Espejo, A., Herranz, M.T., Losada, M., Martinez-Valle, F., Blanco-Daroca, M., Aizpurua-Manso, I., Artaraz, J., Perales-Fraile, I., García-Gil de Bernabé, J., Santander-García, D., Esteban-Marcos, E., Pallares-Ferreres, L., Olea-Vallejo, J.L., Mateo-Poch, J.M., Aragón-Roca, J.A.
Publikováno v:
Revista Clínica Española; April 2021, Vol. 221 Issue: 4 p221-225, 5p